{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:50:05Z","timestamp":1792705805016,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":761,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Integrating host and HBV characteristics, this study aimed to develop models for predicting long-term cirrhosis and hepatocellular carcinoma (HCC) risk in chronic hepatitis B virus (HBV) patients. This analysis included hepatitis B surface antigen (HBsAg)-seropositive and anti-HCV-seronegative participants from the Risk Evaluation of Viral Load Elevation and Associated Liver Disease\/Cancer in HBV (R.E.V.E.A.L.-HBV) cohort. Newly developed cirrhosis and HCC were ascertained through regular follow-up ultrasonography, computerized linkage with national health databases, and medical chart reviews. Two-thirds of the participants were allocated for risk model derivation and another one-third for model validation. The risk prediction model included age, gender, HBV e antigen (HBeAg) serostatus, serum levels of HBV DNA, and alanine aminotransferase (ALT), quantitative serum HBsAg levels, and HBV genotypes. Additionally, the family history was included in the prediction model for HCC. Cox's proportional hazards regression coefficients for cirrhosis and HCC predictors were converted into risk scores. The areas under receiver operating curve (AUROCs) were used to evaluate the performance of risk models. Elder age, male, HBeAg, genotype C, and increasing levels of ALT, HBV DNA, and HBsAg were all significantly associated with an increased risk of cirrhosis and HCC. The risk scores estimated from the derivation set could accurately categorize participants with low, medium, and high cirrhosis and HCC risk in the validation set (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.001). The AUROCs for predicting 3-year, 5-year, and 10-year cirrhosis risk ranged 0.83-0.86 and 0.79-0.82 for the derivation and validation sets, respectively. The AUROC for predicting 5-year, 10-year, 15-year risk of HCC ranged 0.86-0.89 and 0.84-0.87 in the derivation and validation sets, respectively.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion\n                                 <\/jats:bold>\n                                 <jats:bold>: The risk prediction models of cirrhosis and HCC by integrating host and HBV profiles have excellent prediction accuracy and discriminatory ability. They may be used for clinical management of chronic hepatitis B patients. (Hepatology 2013;58:546-554)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26385","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T01:47:31Z","timestamp":1363398451000},"page":"546-554","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":293,"title":["Prediction Models of Long-Term Cirrhosis and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: Risk Scores Integrating Host and Virus Profiles"],"prefix":"10.1097","volume":"58","author":[{"given":"Mei-Hsuan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwai-I.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Batrla-Utermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Lan","family":"Jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uchenna H.","family":"Iloeje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Lin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20241201","doi-asserted-by":"crossref","first-page":"582592","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection.","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"R2-15-20241201","doi-asserted-by":"crossref","first-page":"369370","DOI":"10.1126\/science.8211155","article-title":"From hepatitis to hepatoma: lessons from type B viral hepatitis.","volume":"262","author":"Chen","year":"1993","journal-title":"Science"},{"key":"R3-15-20241201","doi-asserted-by":"crossref","first-page":"529538","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"R4-15-20241201","doi-asserted-by":"crossref","first-page":"191211","DOI":"10.1016\/j.cld.2004.12.009","article-title":"Epidemiology of hepatocellular carcinoma.","volume":"9","author":"Bosch","year":"2005","journal-title":"Clin Liver Dis"},{"key":"R5-15-20241201","doi-asserted-by":"crossref","first-page":"S294S308","DOI":"10.1111\/j.1440-1746.1997.tb00513.x","article-title":"Epidemiological characteristics and risk factors of hepatocellular carcinoma.","volume":"12","author":"Chen","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-15-20241201","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology.","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"R7-15-20241201","doi-asserted-by":"crossref","first-page":"E1E9","DOI":"10.1002\/hep.24473","article-title":"Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review.","volume":"54","author":"Liaw","year":"2011","journal-title":"Hepatology"},{"key":"R8-15-20241201","doi-asserted-by":"crossref","first-page":"12321241","DOI":"10.1002\/hep.23803","article-title":"A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B.","volume":"52","author":"Chan","year":"2010","journal-title":"Hepatology"},{"key":"R9-15-20241201","doi-asserted-by":"crossref","first-page":"508513","DOI":"10.1016\/j.jhep.2010.01.007","article-title":"Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.","volume":"52","author":"Nguyen","year":"2010","journal-title":"J Hepatol"},{"key":"R10-15-20241201","doi-asserted-by":"crossref","first-page":"11401149","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"key":"R11-15-20241201","first-page":"6876","article-title":"Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.","volume":"55","author":"Tseng","year":"2012","journal-title":"Hepatology"},{"key":"R12-15-20241201","doi-asserted-by":"crossref","first-page":"335352","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"R13-15-20241201","doi-asserted-by":"crossref","first-page":"678686","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"R14-15-20241201","doi-asserted-by":"crossref","first-page":"10391047","DOI":"10.1093\/oxfordjournals.aje.a009060","article-title":"Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.","volume":"145","author":"Yu","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R15-15-20241201","doi-asserted-by":"crossref","first-page":"554559","DOI":"10.1016\/S0016-5085(00)70261-7","article-title":"Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B.","volume":"118","author":"Kao","year":"2000","journal-title":"Gastroenterology"},{"key":"R16-15-20241201","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R17-15-20241201","doi-asserted-by":"crossref","first-page":"168174","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma.","volume":"347","author":"Yang","year":"2002","journal-title":"N Engl J Med"},{"key":"R18-15-20241201","doi-asserted-by":"crossref","first-page":"11341143","DOI":"10.1093\/jnci\/djn243","article-title":"Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.","volume":"100","author":"Yang","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R19-15-20241201","doi-asserted-by":"crossref","first-page":"265272","DOI":"10.1093\/jnci\/dji043","article-title":"Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.","volume":"97","author":"Yu","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R20-15-20241201","doi-asserted-by":"crossref","first-page":"16601665","DOI":"10.1200\/JCO.2009.26.2675","article-title":"Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.","volume":"28","author":"Wong","year":"2010","journal-title":"J Clin Oncol"},{"key":"R21-15-20241201","doi-asserted-by":"crossref","first-page":"24372444","DOI":"10.1200\/JCO.2009.27.4456","article-title":"Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.","volume":"28","author":"Yang","year":"2010","journal-title":"J Clin Oncol"},{"key":"R22-15-20241201","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.","volume":"50","author":"Yuen","year":"2009","journal-title":"J Hepatol"},{"key":"R23-15-20241201","first-page":"421430","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona2000 EASL conference. European Association for the Study of the Liver.","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"R24-15-20241201","doi-asserted-by":"crossref","first-page":"16311660","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions.","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"R25-15-20241201","doi-asserted-by":"crossref","first-page":"11871192","DOI":"10.1002\/hep.21612","article-title":"HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a longterm followup.","volume":"45","author":"Chu","year":"2007","journal-title":"Hepatology"},{"key":"R26-15-20241201","doi-asserted-by":"crossref","first-page":"627631","DOI":"10.1002\/hep.1840130403","article-title":"Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study.","volume":"13","author":"Liaw","year":"1991","journal-title":"Hepatology"},{"key":"R27-15-20241201","doi-asserted-by":"crossref","first-page":"474482","DOI":"10.1053\/j.gastro.2010.04.048","article-title":"Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a communitybased followup study.","volume":"139","author":"Liu","year":"2010","journal-title":"Gastroenterology"},{"key":"R28-15-20241201","doi-asserted-by":"crossref","first-page":"15311537","DOI":"10.1002\/hep.23464","article-title":"Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.","volume":"51","author":"Simonetti","year":"2010","journal-title":"Hepatology"},{"key":"R29-15-20241201","doi-asserted-by":"crossref","first-page":"517525","DOI":"10.1053\/j.gastro.2011.04.046","article-title":"Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.","volume":"141","author":"Tseng","year":"2011","journal-title":"Gastroenterology"},{"key":"R30-15-20241201","doi-asserted-by":"crossref","first-page":"11921199","DOI":"10.1053\/j.gastro.2008.07.008","article-title":"HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.","volume":"135","author":"Yuen","year":"2008","journal-title":"Gastroenterology"},{"key":"R31-15-20241201","doi-asserted-by":"crossref","first-page":"251257","DOI":"10.1016\/0166-3542(94)90022-1","article-title":"Measurement of HBsAg to monitor hepatitis B viral replication in patients on alphainterferon therapy.","volume":"23","author":"Janssen","year":"1994","journal-title":"Antiviral Res"},{"key":"R32-15-20241201","doi-asserted-by":"crossref","first-page":"292296","DOI":"10.1016\/j.jcv.2010.12.008","article-title":"Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.","volume":"50","author":"Wursthorn","year":"2011","journal-title":"J Clin Virol"},{"key":"R33-15-20241201","doi-asserted-by":"crossref","first-page":"217222","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay.","volume":"115","author":"Deguchi","year":"2004","journal-title":"J Virol Methods"},{"key":"R34-15-20241201","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1002\/hep.24615","article-title":"Determinants of spontaneous surface antigen loss in hepatitis B e antigennegative patients with a low viral load.","volume":"55","author":"Tseng","year":"2012","journal-title":"Hepatology"},{"key":"R35-15-20241201","doi-asserted-by":"crossref","first-page":"483490","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.","volume":"139","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"key":"R36-15-20241201","first-page":"227242","article-title":"Guidelines: management of chronic hepatitis B.","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"R37-15-20241201","doi-asserted-by":"crossref","first-page":"568574","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACHB): development and validation of a predictive score.","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26385","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201308000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:16:14Z","timestamp":1733062574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201308000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26385","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}